Neoadjuvant Intravesical Vaccine Therapy in Treating Patients With Bladder Carcinoma Who Are Undergoing Cystectomy

Clinical trial NCT00072137 · TERMINATED

Trial details

NCT number: NCT00072137
Sponsor: National Cancer Institute (NCI)
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Bladder Adenocarcinoma Bladder Squamous Cell Carcinoma Bladder Urothelial Carcinoma Recurrent Bladder Carcinoma Stage I Bladder Cancer Stage II Bladder Cancer Stage III Bladder Cancer Stage IV Bladder Cancer

Start date: 2003-10-01
Primary completion: 2009-12-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.